HIV postexposure prophylaxis availability in U.S. rural hospitals

American Journal of Health-System Pharmacy

Volumn 65, Issue 19, 2008, Pages 1796-1797

  Cocohoba, Jennifer ^a   Ramay, Brooke ^a   Patterson, Suzannah ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR PHOSPHATE; ANTIRETROVIRUS AGENT; ATAZANAVIR; EFAVIRENZ; EMTRICITABINE; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; RITONAVIR BOOSTED INDINAVIR; RITONAVIR BOOSTED SAQUINAVIR; STAVUDINE; TENOFOVIR; UNCLASSIFIED DRUG; ZIDOVUDINE;

CLINICAL PROTOCOL; DISEASE SEVERITY; DRUG STORAGE; HEALTH CARE AVAILABILITY; HEALTH SURVEY; HIGH RISK POPULATION; HOSPITAL PHARMACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; LETTER; MEDICAL EDUCATION; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; PHARMACIST; POSTEXPOSURE PROPHYLAXIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; RESPONSIBILITY; RISK BENEFIT ANALYSIS; RURAL HEALTH CARE; SEROCONVERSION; TABLET; UNITED STATES;

EID: 54749122485     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060441     Document Type: Letter

References (4)

1. Cardo DM, Culver DH, Ciesielski CA et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med. 1997; 337:1485-90.
2. Centers for Disease Control and Prevention. Updated U.S. public health service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep. 2001; 29(RR-11):1-52.
3. Panlilio AL, Cardo DM, Grohskopf LA et al. Updated U.S. public health service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep. 2005; 54(RR-9):1-17.
4. Centers for Disease Control and Prevention. HIV/AIDS surveillance supplemental report: HIV/AIDS in urban and rural areas of the United States. Atlanta, GA: Centers for Disease Control and Prevention; 2000:2-12.